Clincosm LogoSign in Get a demo

acute lymphoblastic leukemia, adult

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, Acute Lymphoblastic Leukemia, Adult Trial in Atlanta (Fludarabine,

Not yet recruiting
  • Non-hodgkin Lymphoma,B Cell
  • +2 more
  • Atlanta, Georgia
    Caitlin Guzowski
Jun 9, 2023

Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

Not yet recruiting
  • Bone Marrow Transplant Complications
  • +4 more
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • Invasive Fungal Infections
    • observation of invasive fungal infections
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Feb 20, 2023

    Acute Lymphoblastic Leukemia, Adult Trial in Caba (Evaluation of survival and toxicities in AYA Ph-negative ALL patients

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.
    • Paraná, Entre Ríos, Argentina
    • +1 more
    Dec 29, 2022

    Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Ponatinib 15 MG Oral Tablet
    • Brno, Czechia
    • +6 more
    Nov 30, 2022

    Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, Pediatric Trial in Denmark,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Copenhagen, Denmark
    • +16 more
    Jan 26, 2022

    Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • (no location specified)
    Dec 28, 2020

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic

    Unknown status
    • Acute Lymphoblastic Leukemia, in Relapse
    • +2 more
    • CD19-CAR-T2 Cells
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Oct 25, 2020

    Acute Lymphoblastic Leukemia, Adult Trial in Mexico City (Gemcitabine, Busulfan, Cyclophosphamide)

    Unknown status
    • Acute Lymphoblastic Leukemia, Adult
    • Mexico City, Distrito Federal, Mexico
      Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
    Jan 10, 2020

    B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell

    Unknown status
    • B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation
    • +4 more
    • Blinatumomab in combination with donor lymphocyte infusion
    • Munich, Germany
      Klinikum der Universität München
    Jun 13, 2019